CareDx (CDNA) Competitors

$20.59 +0.62 (+3.10%)

Closing price 05/18/2026 04:00 PM Eastern

Extended Trading

$20.27 -0.32 (-1.54%)

As of 07:02 AM Eastern

CDNA vs. SHC, BLLN, VCYT, OPCH, and CON

Should you buy CareDx stock or one of its competitors? MarketBeat compares CareDx with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with CareDx include Sotera Health (SHC), Billiontoone (BLLN), Veracyte (VCYT), Option Care Health (OPCH), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

How does CareDx compare to Sotera Health?

Sotera Health (NASDAQ:SHC) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their media sentiment, risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.

91.0% of Sotera Health shares are owned by institutional investors. 15.4% of Sotera Health shares are owned by insiders. Comparatively, 4.4% of CareDx shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Sotera Health has a net margin of 9.91% compared to CareDx's net margin of -2.01%. Sotera Health's return on equity of 39.73% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Sotera Health	9.91%	39.73%	7.05%
CareDx	-2.01%	-2.65%	-1.96%

Sotera Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Sotera Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sotera Health	$1.16B	3.76	$77.94M	$0.41	37.44
CareDx	$379.80M	2.80	-$21.35M	-$0.16	N/A

Sotera Health has a beta of 1.82, meaning that its stock price is 82% more volatile than the broader market. Comparatively, CareDx has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market.

Sotera Health currently has a consensus target price of $20.33, suggesting a potential upside of 32.46%. CareDx has a consensus target price of $25.00, suggesting a potential upside of 21.42%. Given Sotera Health's stronger consensus rating and higher probable upside, research analysts clearly believe Sotera Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sotera Health	0 Sell rating(s)	3 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.70
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

In the previous week, Sotera Health had 5 more articles in the media than CareDx. MarketBeat recorded 5 mentions for Sotera Health and 0 mentions for CareDx. CareDx's average media sentiment score of 0.75 beat Sotera Health's score of 0.73 indicating that CareDx is being referred to more favorably in the news media.

Company	Overall Sentiment
Sotera Health	Positive
CareDx	Positive

Summary

Sotera Health beats CareDx on 14 of the 16 factors compared between the two stocks.

How does CareDx compare to Billiontoone?

CareDx (NASDAQ:CDNA) and Billiontoone (NASDAQ:BLLN) are both healthcare companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, media sentiment, dividends, earnings and risk.

Billiontoone has a net margin of 0.00% compared to CareDx's net margin of -2.01%. Billiontoone's return on equity of 0.00% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Billiontoone	N/A	N/A	N/A

CareDx presently has a consensus price target of $25.00, suggesting a potential upside of 21.42%. Billiontoone has a consensus price target of $125.29, suggesting a potential upside of 45.48%. Given Billiontoone's stronger consensus rating and higher possible upside, analysts clearly believe Billiontoone is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Billiontoone	1 Sell rating(s)	3 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.50

Billiontoone has lower revenue, but higher earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Billiontoone, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	2.80	-$21.35M	-$0.16	N/A
Billiontoone	$305.11M	12.98	$7.45M	$0.55	156.58

In the previous week, Billiontoone had 5 more articles in the media than CareDx. MarketBeat recorded 5 mentions for Billiontoone and 0 mentions for CareDx. CareDx's average media sentiment score of 0.75 beat Billiontoone's score of 0.27 indicating that CareDx is being referred to more favorably in the media.

Company	Overall Sentiment
CareDx	Positive
Billiontoone	Neutral

Summary

Billiontoone beats CareDx on 11 of the 13 factors compared between the two stocks.

How does CareDx compare to Veracyte?

CareDx (NASDAQ:CDNA) and Veracyte (NASDAQ:VCYT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, institutional ownership, valuation, earnings, risk, media sentiment, dividends and profitability.

In the previous week, Veracyte had 5 more articles in the media than CareDx. MarketBeat recorded 5 mentions for Veracyte and 0 mentions for CareDx. CareDx's average media sentiment score of 0.75 beat Veracyte's score of 0.69 indicating that CareDx is being referred to more favorably in the media.

Company	Overall Sentiment
CareDx	Positive
Veracyte	Positive

Veracyte has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Veracyte, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	2.80	-$21.35M	-$0.16	N/A
Veracyte	$517.15M	6.40	$66.35M	$1.09	38.07

Veracyte has a net margin of 16.25% compared to CareDx's net margin of -2.01%. Veracyte's return on equity of 9.07% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Veracyte	16.25%	9.07%	8.38%

CareDx has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market. Comparatively, Veracyte has a beta of 1.89, meaning that its stock price is 89% more volatile than the broader market.

CareDx currently has a consensus target price of $25.00, suggesting a potential upside of 21.42%. Veracyte has a consensus target price of $44.83, suggesting a potential upside of 8.03%. Given CareDx's higher probable upside, equities research analysts plainly believe CareDx is more favorable than Veracyte.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Veracyte	1 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.38

Summary

Veracyte beats CareDx on 11 of the 14 factors compared between the two stocks.

How does CareDx compare to Option Care Health?

Option Care Health (NASDAQ:OPCH) and CareDx (NASDAQ:CDNA) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

Option Care Health has a beta of 0.68, meaning that its share price is 32% less volatile than the broader market. Comparatively, CareDx has a beta of 2.49, meaning that its share price is 149% more volatile than the broader market.

Option Care Health presently has a consensus target price of $31.25, indicating a potential upside of 58.71%. CareDx has a consensus target price of $25.00, indicating a potential upside of 21.42%. Given Option Care Health's stronger consensus rating and higher possible upside, equities research analysts plainly believe Option Care Health is more favorable than CareDx.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Option Care Health	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.69
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

Option Care Health has a net margin of 3.64% compared to CareDx's net margin of -2.01%. Option Care Health's return on equity of 18.17% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Option Care Health	3.64%	18.17%	7.16%
CareDx	-2.01%	-2.65%	-1.96%

98.1% of Option Care Health shares are owned by institutional investors. 1.7% of Option Care Health shares are owned by company insiders. Comparatively, 4.4% of CareDx shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Option Care Health has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Option Care Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Option Care Health	$5.65B	0.55	$207.59M	$1.29	15.26
CareDx	$379.80M	2.80	-$21.35M	-$0.16	N/A

In the previous week, Option Care Health had 14 more articles in the media than CareDx. MarketBeat recorded 14 mentions for Option Care Health and 0 mentions for CareDx. Option Care Health's average media sentiment score of 0.78 beat CareDx's score of 0.75 indicating that Option Care Health is being referred to more favorably in the media.

Company	Overall Sentiment
Option Care Health	Positive
CareDx	Positive

Summary

Option Care Health beats CareDx on 14 of the 17 factors compared between the two stocks.

How does CareDx compare to Concentra Group Holdings Parent?

CareDx (NASDAQ:CDNA) and Concentra Group Holdings Parent (NYSE:CON) are both medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, risk, earnings, analyst recommendations, institutional ownership, valuation and media sentiment.

CareDx has a beta of 2.49, meaning that its stock price is 149% more volatile than the broader market. Comparatively, Concentra Group Holdings Parent has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

Concentra Group Holdings Parent has a net margin of 7.97% compared to CareDx's net margin of -2.01%. Concentra Group Holdings Parent's return on equity of 47.14% beat CareDx's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
CareDx	-2.01%	-2.65%	-1.96%
Concentra Group Holdings Parent	7.97%	47.14%	6.48%

Concentra Group Holdings Parent has higher revenue and earnings than CareDx. CareDx is trading at a lower price-to-earnings ratio than Concentra Group Holdings Parent, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
CareDx	$379.80M	2.80	-$21.35M	-$0.16	N/A
Concentra Group Holdings Parent	$2.16B	1.54	$166.41M	$1.39	18.78

CareDx presently has a consensus price target of $25.00, indicating a potential upside of 21.42%. Concentra Group Holdings Parent has a consensus price target of $30.25, indicating a potential upside of 15.89%. Given CareDx's higher probable upside, research analysts plainly believe CareDx is more favorable than Concentra Group Holdings Parent.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
CareDx	1 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Concentra Group Holdings Parent	0 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.83

In the previous week, Concentra Group Holdings Parent had 6 more articles in the media than CareDx. MarketBeat recorded 6 mentions for Concentra Group Holdings Parent and 0 mentions for CareDx. CareDx's average media sentiment score of 0.75 beat Concentra Group Holdings Parent's score of 0.41 indicating that CareDx is being referred to more favorably in the media.

Company	Overall Sentiment
CareDx	Positive
Concentra Group Holdings Parent	Neutral

Summary

Concentra Group Holdings Parent beats CareDx on 10 of the 14 factors compared between the two stocks.

Get CareDx News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDNA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

CDNA vs. The Competition

Export

Metric	CareDx	Medical Services Industry	Medical Sector	NASDAQ Exchange
Market Cap	$1.03B	$8.17B	$6.25B	$12.29B
Dividend Yield	N/A	3.06%	2.80%	5.32%
P/E Ratio	-128.69	22.08	20.64	25.23
Price / Sales	2.80	20.97	554.85	79.36
Price / Cash	N/A	12.21	27.48	37.30
Price / Book	3.50	4.84	9.66	6.63
Net Income	-$21.35M	$183.43M	$3.56B	$335.59M
7 Day Performance	-3.79%	-1.50%	-1.65%	-1.20%
1 Month Performance	-3.87%	-0.92%	-2.60%	-1.16%
1 Year Performance	16.33%	0.22%	30.07%	28.10%

CareDx Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count
CDNA CareDx	2.6189 of 5 stars	$20.59 +3.1%	$25.00 +21.4%	+17.4%	$1.03B	$379.80M	N/A	740
SHC Sotera Health	3.9251 of 5 stars	$15.43 -2.2%	$20.33 +31.8%	+19.9%	$4.50B	$1.19B	37.64	3,000
BLLN Billiontoone	4.0105 of 5 stars	$105.94 +14.0%	$122.43 +15.6%	N/A	$4.27B	$305.11M	504.48	620
VCYT Veracyte	2.4088 of 5 stars	$39.70 -1.8%	$44.83 +12.9%	+42.1%	$3.23B	$517.15M	36.42	790
OPCH Option Care Health	4.9375 of 5 stars	$19.83 -3.3%	$31.25 +57.6%	-40.7%	$3.22B	$5.65B	15.37	8,266

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:CDNA) was last updated on 5/19/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CareDx (CDNA) Competitors

CDNA vs. SHC, BLLN, VCYT, OPCH, and CON

How does CareDx compare to Sotera Health?

Summary

How does CareDx compare to Billiontoone?

Summary

How does CareDx compare to Veracyte?

Summary

How does CareDx compare to Option Care Health?

Summary

How does CareDx compare to Concentra Group Holdings Parent?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDNA vs. The Competition

CareDx Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

CareDx (CDNA) Competitors

CDNA vs. SHC, BLLN, VCYT, OPCH, and CON

How does CareDx compare to Sotera Health?

Do insiders & institutionals have more ownership in SHC or CDNA?

Is SHC or CDNA more profitable?

Which has better earnings and valuation, SHC or CDNA?

Which has more volatility and risk, SHC or CDNA?

Do analysts recommend SHC or CDNA?

Does the media refer more to SHC or CDNA?

Summary

How does CareDx compare to Billiontoone?

Is CDNA or BLLN more profitable?

Do analysts rate CDNA or BLLN?

Which has stronger earnings and valuation, CDNA or BLLN?

Does the media refer more to CDNA or BLLN?

Summary

How does CareDx compare to Veracyte?

Does the media favor CDNA or VCYT?

Which has better valuation & earnings, CDNA or VCYT?

Is CDNA or VCYT more profitable?

Which has more risk and volatility, CDNA or VCYT?

Do analysts prefer CDNA or VCYT?

Summary

How does CareDx compare to Option Care Health?

Which has more volatility & risk, OPCH or CDNA?

Do analysts rate OPCH or CDNA?

Is OPCH or CDNA more profitable?

Do institutionals & insiders believe in OPCH or CDNA?

Which has stronger valuation & earnings, OPCH or CDNA?

Does the media prefer OPCH or CDNA?

Summary

How does CareDx compare to Concentra Group Holdings Parent?

Which has more volatility and risk, CDNA or CON?

Is CDNA or CON more profitable?

Which has higher valuation & earnings, CDNA or CON?

Do analysts prefer CDNA or CON?

Does the media prefer CDNA or CON?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

CDNA vs. The Competition

CareDx Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools